Cargando…
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
The clinical responses observed following treatment with immune checkpoint inhibitors (ICIs) support immunotherapy as a potential anticancer treatment. However, a large proportion of patients cannot benefit from it due to resistance or relapse, which is most likely attributable to the multiple immun...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513992/ https://www.ncbi.nlm.nih.gov/pubmed/36163047 http://dx.doi.org/10.1186/s12943-022-01657-y |